Neuropsychopharmacology

• 

  Publication Venue For

  • Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring..  47:1755-1763. 2022
  • Organization of the social cognition network predicts future depression and interpersonal impairment: a prospective family-based study.  47:531-542. 2022
  • Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk..  46:2304-2311. 2021
  • Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model..  44:245-258. 2019
  • Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons..  42:615-627. 2017
  • A Functional Interleukin-18 Haplotype Predicts Depression and Anxiety through Increased Threat-Related Amygdala Reactivity in Women but Not Men..  42:419-426. 2017
  • Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse..  42:156-177. 2017
  • Genetic Moderation of Stress Effects on Corticolimbic Circuitry..  41:275-296. 2016
  • Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults.  40:2745-2752. 2015
  • Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children..  39:1245-1253. 2014
  • Enhancement of rTMS Neuromodulatory Effects with Novel Waveforms Demonstrated via Controllable Pulse Parameter TMS (cTMS).  38:S246-S247. 2013
  • Optimizing Stimulus Pulse Characteristics for Transcranial Magnetic Stimulation and Electroconvulsive Therapy via Device Development, Computational Modeling, and Biophysically-motivated Dosing Paradigms.  38:S30-S31. 2013
  • The Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Verbal Learning and Memory.  38:S426-S427. 2013
  • Erratum: Focal electrically administered seizure therapy: A novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction (Neuropsychopharmacology (2009) 34 (2002-2010) DOI: 10.1038/npp.2009.12).  37:1077. 2012
  • Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity..  36:1940-1947. 2011
  • Fluoxetine Alleviates Behavioral Depression while Decreasing Acetylcholine Release in the Nucleus Accumbens Shell.  36:1729-1737. 2011
  • Acute 5-HT reuptake blockade potentiates human amygdala reactivity..  33:3221-3225. 2008
  • Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues..  33:2148-2157. 2008
  • Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial..  33:1217-1228. 2008
  • ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia..  33:957-970. 2008
  • Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys..  33:270-278. 2008
  • Imaging genetics offers new predictive markers of individual differences in behavior and risk for psychiatric diseases.  33:201-202. 2008
  • Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention..  32:2453-2464. 2007
  • Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care..  32:2479-2489. 2007
  • Regional brain activity correlates of nicotine dependence..  32:2441-2452. 2007
  • Prefrontal white matter lesions and prefrontal task impersistence in depressed and nondepressed elders..  32:2135-2142. 2007
  • Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age..  32:1082-1097. 2007
  • Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders..  32:257-262. 2007
  • Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors..  32:377-387. 2007
  • Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics..  32:95-102. 2007
  • Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling..  31:2462-2475. 2006
  • Erratum: VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms (Neuropsychopharmacology (2006) 31 (1345-1355) DOI: 10.1038/sj.npp.1301082).  31:2329. 2006
  • Baseline neurocognitive deficits in the CATIE schizophrenia trial..  31:2033-2046. 2006
  • Report by the ACNP Task Force on response and remission in major depressive disorder..  31:1841-1853. 2006
  • The G72/G30 gene complex and cognitive abnormalities in schizophrenia..  31:2022-2032. 2006
  • Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability..  31:1647-1658. 2006
  • Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell..  31:1444-1451. 2006
  • Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN)..  31:1500-1507. 2006
  • VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms..  31:1345-1355. 2006
  • Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking..  31:1550-1561. 2006
  • Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics..  31:1249-1263. 2006
  • Sex differences in neurochemical effects of dopaminergic drugs in rat striatum..  31:1193-1202. 2006
  • Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems..  31:904-911. 2006
  • Increased pituitary volume in ...psychosis study..  31:243. 2006
  • Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity..  31:12-35. 2006
  • Cortical white matter microstructural abnormalities in bipolar disorder..  30:2225-2229. 2005
  • Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues..  30:1940-1947. 2005
  • Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses..  30:1841-1855. 2005
  • Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene..  30:1818-1831. 2005
  • Trauma, proximity, and developmental psychopathology: the effects of war and terrorism on children..  30:1781-1792. 2005
  • Erratum: Novelty seeking and stereotypic activation of behavior in mice with disruption of the DatI gene (Neuropsychopharmacology (April 27, 2005), DOI:10.1038/sj.npp.1300724).  30:1772. 2005
  • Gestational dexamethasone treatment elicits sex-dependent alterations in locomotor activity, reward-based memory and hippocampal cholinergic function in adolescent and adult rats..  30:1617-1623. 2005
  • Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions..  30:1121-1127. 2005
  • Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy..  30:445-460. 2005
  • Medical comorbidity in a bipolar outpatient clinical population..  30:401-404. 2005
  • Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients..  30:405-416. 2005
  • Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys..  30:129-144. 2005
  • Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital..  30:156-165. 2005
  • Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats..  30:52-57. 2005
  • A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future..  29:2285-2299. 2004
  • Is there a definition of remission in late-life depression that predicts later relapse?.  29:2272-2277. 2004
  • Prefrontal neuropsychological predictors of treatment remission in late-life depression..  29:2266-2271. 2004
  • Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence?.  29:1440-1450. 2004
  • Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal..  29:879-890. 2004
  • Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls..  28:2179-2183. 2003
  • Magnetic seizure therapy improves mood in refractory major depression..  28:2045-2048. 2003
  • Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds..  28:1935-1949. 2003
  • Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy..  28:1852-1865. 2003
  • Serotonin-related gene polymorphisms and central nervous system serotonin function..  28:533-541. 2003
  • Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents..  28:1-13. 2003
  • Dextroamphetamine modulates the response of the human amygdala..  27:1036-1040. 2002
  • Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia..  27:684-686. 2002
  • Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats..  27:534-541. 2002
  • Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants..  27:319-328. 2002
  • Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome..  25:713-728. 2001
  • Subtypes of mania determined by grade of membership analysis..  25:373-383. 2001
  • Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline..  25:131-138. 2001
  • Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy..  25:118-130. 2001
  • Clinician, parent, and child prediction of medication or placebo in double-blind depression study..  23:591-594. 2000
  • Hippocampal remodeling and damage by corticosteroids: implications for mood disorders..  21:474-484. 1999
  • Effects of fluoxetine on the polysomnogram in outpatients with major depression..  20:447-459. 1999
  • Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome..  20:162-176. 1999
  • Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?.  19:434-444. 1998
  • Gender difference in cocaine-induced HPA axis activation..  16:399-407. 1997
  • Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia..  15:587-594. 1996
  • Nicotine-haloperidol interactions and cognitive performance in schizophrenics..  15:429-436. 1996
  • MAOIs in the contemporary treatment of depression..  12:185-219. 1995
  • Fluoxetine and oculomotor activity during sleep in depressed patients..  12:159-165. 1995
  • The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study..  10:85-91. 1994
  • The effects of nefazodone on sleep architecture in depression..  10:123-127. 1994
  • Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging..  10:29-35. 1994
  • CATECHOLAMINE RECEPTORS - MOLECULAR CHARACTERIZATION AND PHYSIOLOGICAL IMPLICATIONS.  9:S35-S36. 1993
  • Low plasma GABA is a trait-like marker for bipolar illness..  9:125-132. 1993
  • Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia..  6:119-125. 1992
  • Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity..  4:87-93. 1991
  • Effects of propranolol on cardiovascular and neuroendocrine responses to mental arithmetic in type A men..  1:337-340. 1988
  • Reduced rapid eye movement latency. A predictor of recurrence in depression..  1:33-39. 1987
  • Probing Disparities in Exposure to Smoking Contexts Using Computer Vision 2022
  • Amplification of the Effects of Adolescent Binge Alcohol Exposure by Pretreatment With an Alpha-7 Nicotinic Receptor Positive Allosteric Modulator 2021
  • Antidepressant Response of Electroconvulsive Therapy and Magnetic Seizure Therapy: Response Trajectories by Symptom Clusters 2021
  • Baseline Memory Function Affects Memory Outcome in Older Adults With Major Depressive Disorder Treated With Acute Course Electroconvulsive Therapy and Venlafaxine 2021
  • Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development? 2021
  • Translational Drug Development for Pediatric CNS Disorders 2021
  • Acute Effects of Electroconvulsive Therapy and Venlafaxine on Verbal Learning and Memory Dimensions in Older Adults With Major Depressive Disorder 2020
  • Aggression: Gaps in our Knowledge and Strategies to Enhance Research in the Field 2020
  • BI 425809 Once Daily in Patients With Schizophrenia: Feasibility of Novel Endpoints to Assess Motivation 2020
  • Embedded Temporal Patterns in the Feedback Signal Differentially Predict VTA Neurofeedback-Mediated Learning to Self-Regulate Motivation 2020
  • Exposure to Smoking Context Potentiates Habitual Motor Response 2020
  • Impact of Daily Caffeine on Actigraphically-Measured Sleep Duration Among Adolescents With and Without Attention-Deficit/Hyperactivity Disorder 2020
  • Neural Correlates of Social Reward Processing Differ Between Young Adult Smokers and Non-Smokers 2020
  • Sex Differences in Conditioned Taste Aversion 2020
  • Androsterone and DHEAS are Inversely Associated With Pain Symptoms in Male Iraq/Afghanistan-Era Veterans 2019
  • Associations Between Sleep, Neurocognitive Performance, and ADHD Symptom Severity Among Adolescents 2019
  • Neural Mechanisms Underlying Effects of Propranolol on Drug Cue Reactivity 2019
  • Neuropsychopharmacology (NPP) Special Projects: Update on Gender Balance in NPP Function and Examination of Relationships Between Social Media and Citation Counts 2019
  • Neurosteroids in TBI: Biomarkers to Therapeutics 2019
  • Artificial Intelligence as a Transformative Force for Research and Practice in Neuropsychiatric Disorders: A Realistic Aspiration or a Magical Fantasy? 2019
  • Cognitive Control Across the Spectrum of Major Depressive Disorder 2019
  • Online Repetitive Transcranial Magnetic Stimulation Enhances Working Memory Performance in Younger and Older Adults 2018
  • Rapastinel, a Nonopioid Pharmacotherapy for Opioid Dependence? 2018
  • Real-Time fMRI as a CBT Adjunct: Predicting the Behavioral Impact of Neurofeedback 2018
  • Informing the Complex Association Between Depression Symptom Severity and Neurocognitive Function in Geriatric Major Depressive Disorder 2018
  • Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials 2017
  • Conditioned Food Avoidance in Adolescence: A Contributor to Eating Disorders? 2017
  • Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats 2017
  • Increased Activation in Precuneus and Parahippocampus When Smokers View Tobacco Retail Outlets: Results of a GPS plus fMRI 'Community Neuroscience' Study 2017
  • Meta-Analysis of DNA Methylation and PTSD in the Psychiatric Genomics Consortium PTSD Epigenetics Workgroup 2017
  • Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism 2017
  • fMRI- and Computationally-Guided rTMS Enhances Performance in Working Memory Manipulation 2017
  • Electric Field Characteristics of Low-Field Synchronized Transcranial Magnetic Stimulation (sTMS) 2017
  • Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy and Pharmacotherapy in Geriatric Major Depressive Disorder 2017
  • ADHD, Smoking Withdrawal, and Resting State Functional Connectivity: Results of a fMRI Study With Methylphenidate Challenge 2016
  • Cognitive Neurostimulation of the Dopamine System 2016
  • How Do Astrocytes Shape Synaptic Circuits? 2016
  • Initial Response to Intranasal Nicotine Young Adults With and Without Attention Deficit Hyperactivity Disorder 2016
  • Neurocognitive Effects of Combined Electroconvulsive Therapy and Venlafaxine in Elderly Adults With Major Depressive Disorder 2016
  • Adenosine Regulation of Dopamine Release and Behavior in Adolescent Rats 2015
  • Comparing the Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Quality of Life 2015
  • Ethanol Withdrawal in Adolescent and Adult Rats 2015
  • From Good Habit to Bad: Corticostriatal Synaptic and Circuit Mechanisms in Habit and Compulsion 2015
  • Posttraumatic Stress Disorder and Common Genetic Variants Affect Subcortical Brain Volumes in Recent Military Veterans 2015
  • Connectivity Analysis of Eeg in Depressed Patients Receiving Electroconvulsive Therapy and Magnetic Seizure Therapy 2015
  • A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study 2014
  • Dasotraline as a Novel DAT/NET Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-concept Trial in Adults 2014
  • Ethanol Withdrawal in Adolescent and Adult Rat 2014
  • Neuroserpin Protects Parvalbumin Interneurons Against Perineuronal Net Degradation for Cortical Stability 2014
  • The Influence of APOE Genotype on Aging's Effect on Brain Structure and Cognition in Younger Adults with and without Depression 2014
  • Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression 2014
  • Lesions of the Orbitofrontal Cortex Reduce Risk-taking in Rats 2014
  • The Differential Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Autobiographical Memory Specificity 2014
  • Independent Effects of Lps and Social Isolation on Forced Swim Behavior in Female Mice 2013
  • Insights into the Roles of the Methyl-DNA Binding Protein MeCP2 in Addictive-like Behaviors 2013
  • MDPV Has Potent and Atypical Effects on Dopamine Release in Adolescent and Adult Rats 2013
  • Neurosteroids as Novel Therapeutics and Biomarker Candidates in Schizophrenia and PTSD 2013
  • Rapid Reduction in Suicide Risk in Depressed Elderly Treated with Electroconvulsive Therapy (ECT): Data from Phase I of the PRIDE Study 2013
  • A preliminary metabolomic analysis of older adults with and without depression 2006
  • Bupropion reinstates cocaine seeking behavior in rats 2006
  • Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: Candidate mechanism for superior efficacy? 2006
  • Decisional competence to complete psychiatric advance directives 2006
  • Effects of 24 hour smoking abstinence on sustained and event-related brain activity during continuous working memory: Preliminary results of an fMRI study 2006
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial 2006
  • Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia 2006
  • Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial 2006
  • Transcranial magnetic stimulation: Effectiveness and safety in a randomized, controlled, multisite clinical trial and an open-label extension study 2006
  • cTMS: A novel TMS device inducing near rectangular pulses with controllable pulse width 2006
  • 5HTTLPR genotypes and environmental stress interact to affect sleep quality 2005
  • A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with oros methylphenidate in treatment resistant depression 2005
  • Candidate gene polymorphisms and birth weight (BW) in the national longitudinal study of adolescent health (add health) 2005
  • Clozapine effects on memory function are reversed by hippocampal damage 2005
  • Deficit in the GABAergic neuroactive steroid allopregnanolone in Alzheimer's dementia and relevance to neuropathological disease stage: Investigations in temporal cortex 2005
  • Serotonin transporter polymorphism influences the prolactin response to tryptophan and stress 2005
  • The impact of infection early in life on the formation of long-term memories in adulthood 2005
  • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial 2005
  • Randomized controlled trial of the cognitive side effects of magnetic seizure therapy and electroconvulsive shock 2005
  • Effects of treatment with a cyclic peptide that targets PDZ domain of PSD-95: Peptide administration to the ventral tegmental area inhibits opiate-induced motor sensitization in C57BL/6 mice 2004
  • Neuroactive steroid alterations in schizophrenia and bipolar disorder: A negative ion chemical ionization gas chromatography/mass spectrometry investigation in posterior cingulate 2004
  • Neuroactive steroids in Alzheimer's disease: Investigations in prefrontal cortex 2004
  • Plasma amyloid beta 1-42 levels in geriatric depression: A pilot study 2004
  • The neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) predicts nicotine dependence severity 2004
  • Electroconvulsive therapy increases angiogenesis and neurogenesis in the monkey hippocampus 2004
  • Neurocognitive function in individuals "at-risk" for psychosis 2004
  • Neuroendocrine response to magnetic seizure therapy (MST) in major depression: Comparison with electroconvulsive therapy 2004
  • Transcranial magnetic stimulation (TMS) in the treatment of resistant Obsessive-Compulsive Disorder (OCD): Clinical outcomes and neurophysiological correlates 2004